MedPath

Behavioral Health Program for Short-Stay Nursing Facility Residents & Care Partners

Not Applicable
Not yet recruiting
Conditions
Nursing Home Resident
Skilled Nursing Facility
Depression
Feasibility Studies
Caregiver
Registration Number
NCT07220486
Lead Sponsor
Massachusetts General Hospital
Brief Summary

The goal of this clinical trial is to test a behavioral health program (Interventions for Stressful Transitions in Later Life, InSTILL) for skilled nursing facility residents and their primary support person. The main questions it aims to answer is whether the program is program is feasible, satisfactory, and helpful. The researchers will compare the InSTILL program to minimally enhanced usual care. Participants will be randomly assigned to receive either the InSTILL program or minimally enhanced usual care. Participants will complete assessments at three timepoints (all) and a brief-exit interview.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Patient and care partner both aged ≥ 18 years
  • Patient with care partner (known person providing regular health-related, socioemotional, or practical support) willing to participate
  • Patient reporting depression symptoms on a screening tool (Patient Health Questionnaire)
Exclusion Criteria
  • Patient intended length of nursing facility stay < 7 days
  • Patient evidencing more than mild impairment on a cognitive screen (Brief Interview for Mental Status)
  • Patient's roommate in skilled nursing facility already enrolled in study/intervention
  • Either patient or care partner reporting high risk of suicidality, based on a standardized safety assessment tool
  • Either patient or care partner participating in newly initiated psychotherapy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Treatment Credibilityperi-intervention

3-item self-report measure of participant's belief regarding how helpful the intervention will be for them. Higher scores (min = 0, max = 30) scores indicate greater credibility.

Client Satisfaction Questionnaireimmediately after the intervention

3-item self-report measure assessing patient satisfaction with the program. Higher total scores (min = 3, max = 12) indicate greater satisfaction.

Feasibility of Recruitmentbaseline, pre-intervention

Percentage of eligible approached dyads that are enrolled into the study.

Feasibility of Data Collection1 month follow-up

Percentage of all participants with no measure fully missing at follow-up.

Treatment Adherenceimmediately after the intervention

Percentage of InSTILL participants completing 5/8 sessions

Clinician Fidelityimmediately after the intervention

Percentage of InSTILL sessions delivered with 100% adherence on a study-specific Fidelity Checklist.

Adverse Events1 month follow-up

Any adverse events related to participation in the study.

Treatment Acceptability Surveyimmediately after the intervention

Percentage of InSTILL participants scoring above the scale midpoint on all 9 Treatment Acceptability Survey items (developed for the current study).

Secondary Outcome Measures
NameTimeMethod
PHQ-9baseline, pre-intervention; immediately after the intervention; 1 month follow-up

9-item self-report measure of depression symptoms. Higher scores (min=0, max=27) indicate greater depressive symptoms.

Selection, Optimization, and Compensation in Everyday Usebaseline, pre-intervention; immediately after the intervention; 1 month follow-up

4-item self-report measure of the application of selection, optimization, and compensation strategies in daily life.

Committed Action Questionnairebaseline, pre-intervention; immediately after the intervention; 1 month follow-up

8-item self-report measure of pursuit of valued goals despite challenges and difficulties

Perceptions of Collaboration Questionnairebaseline, pre-intervention; immediately after the intervention; 1 month follow-up

12-item self-report measure of dyadic coping, including collaboration and interpersonal enjoyment.

General Anxiety Disorder-7baseline, pre-intervention; immediately after the intervention; 1 month follow-up

7-item self-report measure of anxiety symptoms.

Euro QoL-5D 5Lbaseline, pre-intervention; immediately after the intervention; 1 month follow-up

6-item self-report measure of subjective health-related quality of life.

Relationship Assessment Scalebaseline, pre-intervention; immediately after the intervention; 1 month follow-up

Single-item self-report measure of relationship satisfaction with study partner.

Preparedness for Future Carebaseline, pre-intervention; immediately after the intervention; 1 month follow-up

5-item self-report measure of active preparation for future health care needs.

COREQimmediately after the intervention

4-item self-report of nursing facility satisfaction.

University of Washington Resilience Scale Short Formbaseline, pre-intervention; immediately after the intervention; 1 month follow-up

4-item self-report of an individual's perceived resilience.

Zarit Burden Interviewbaseline, pre-intervention; immediately after the intervention; 1 month follow-up

4-item self-report screener of caregiver burden. Administered to care partners only.

Psychotropic medication usebaseline, pre-intervention; immediately after the intervention; 1 month follow-up

Chart or self reported psychotropic medication use

Re-hospitalizationimmediately after the intervention; 1 month follow-up

Resident re-hospitalization during the study period

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.